Takeda Pharmaceutical Stock Target Price and Analyst Consensus
| TAK Stock | USD 15.01 0.02 0.13% |
The current analyst and expert consensus on Takeda Pharmaceutical is Strong Buy, with 3 strong buy opinions. The current projected Takeda Pharmaceutical target price consensus is 15.72 with 4 analyst opinions. Check out Macroaxis Advice on Takeda Pharmaceutical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. The most common way Takeda Pharmaceutical analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Takeda Pharmaceutical executives and customers to further validate their buy or sell advice. Please note, the number of analysts providing the opinion is not sufficient to provide adequate consensus on Takeda Pharmaceutical. We encourage you to use your own analysis of Takeda Pharmaceutical to validate this buy or sell advice. Takeda Pharmaceutical buy-or-sell recommendation module provides average expert sentiment on the projected Takeda Pharmaceutical target price to derive its highest and lowest estimates based on projected price volatility of 1.1778.
Lowest Forecast 14.3 | Highest Forecast 17.45 | Target Price 15.72 |
Takeda |
It's important to approach Takeda Pharmaceutical's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Takeda Pharmaceutical Target Price Consensus
Takeda target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Takeda Pharmaceutical's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| 4 | Strong Buy |
Most Takeda analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Takeda stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Takeda Pharmaceutical, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationTakeda Pharmaceutical Target Price Projection
Takeda Pharmaceutical's current and average target prices are 15.01 and 15.72, respectively. The current price of Takeda Pharmaceutical is the price at which Takeda Pharmaceutical Co is currently trading. On the other hand, Takeda Pharmaceutical's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Current Price
Takeda Pharmaceutical Market Quote on 15th of March 2025
Target Price
Analyst Consensus On Takeda Pharmaceutical Target Price
Takeda Pharmaceutical Analyst Ratings
Takeda Pharmaceutical's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Takeda Pharmaceutical stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Takeda Pharmaceutical's financials, market performance, and future outlook by experienced professionals. Takeda Pharmaceutical's historical ratings below, therefore, can serve as a valuable tool for investors.Analyst Consensus Breakdown
Average Consensus Estimates
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Takeda Pharmaceutical price targets
Takeda Pharmaceutical's stock target price is an estimate of its future price, usually made by analysts. Using Takeda Pharmaceutical's target price to determine if it is a suitable investment can be done through the following steps:- Look at Takeda Pharmaceutical's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Takeda Pharmaceutical's stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Takeda Pharmaceutical Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Takeda Pharmaceutical is a key component of Takeda Pharmaceutical valuation and have some predictive power on the future returns of a Takeda Pharmaceutical.Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Warren Buffett Holdings Invested few shares | |
 | Artificial Intelligence Invested few shares | |
 | ESG Investing Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Business Services Invested few shares | |
 | Dividend Beast Invested over 60 shares | |
 | Blockchain Invested few shares | |
 | SRI Sustainable Growth Invested over 40 shares | |
 | Apparel Invested over 40 shares | |
 | Casinos Sold over 90 shares | |
 | Macroaxis Index Sold over 90 shares | |
 | Utilities Invested over 90 shares | |
Check out Macroaxis Advice on Takeda Pharmaceutical to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.